Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

Brian G. Feagan, Laurent Peyrin‐Biroulet, Edward V. Loftus et al.|The Lancet|2021

Cited by 452